The Integrated Genomics Shared Resource brings together microarray services and advanced sequencing technology in an established core environment with demonstrated strengths in delivery of high quality data and comprehensive user support. As an integrated resource for genomic technologies, the Integrated Genomics Shared Resource is able to advise Knight members on selection of genomic technologies and applications that best suit their research aims and then effectively support those choices. The facility provides Knight members: 1) access to otherwise costly technology at a reasonable price;(2) in-house consultation for project development, experimental design, and analysis of results;3) rapid turnaround time for genomics services;4) highly-standardized and quality-controlled assays and data preparation;and 5) a stable repository of microarray and sequencing data. Most importantly, the IGL maintains a team of highly knowledgeable and experienced staff that is available to cancer researchers for project design consultation, grant development assistance, assay development collaboration, and data analysis and publication support.

Public Health Relevance

The Integrated Genomics Shared Resource brings together microarray services and advanced sequencing technology in an established core environment with demonstrated strengths in delivery of high quality data and comprehensive user support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA069533-15
Application #
8381620
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
15
Fiscal Year
2012
Total Cost
$68,800
Indirect Cost
$24,882
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Farrell, Amy S; Joly, Meghan Morrison; Allen-Petersen, Brittany L et al. (2017) MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance. Nat Commun 8:1728
De Maria, Alicia; Wilmarth, Phillip A; David, Larry L et al. (2017) Proteomic Analysis of the Bovine and Human Ciliary Zonule. Invest Ophthalmol Vis Sci 58:573-585
Danelishvili, Lia; Chinison, Jessica J J; Pham, Tuan et al. (2017) The Voltage-Dependent Anion Channels (VDAC) of Mycobacterium avium phagosome are associated with bacterial survival and lipid export in macrophages. Sci Rep 7:7007
Avenarius, Matthew R; Krey, Jocelyn F; Dumont, Rachel A et al. (2017) Heterodimeric capping protein is required for stereocilia length and width regulation. J Cell Biol 216:3861-3881
Cassidy, Pamela B; Liu, Tong; Florell, Scott R et al. (2017) A Phase II Randomized Placebo-Controlled Trial of Oral N-acetylcysteine for Protection of Melanocytic Nevi against UV-Induced Oxidative Stress In Vivo. Cancer Prev Res (Phila) 10:36-44
Tsujikawa, Takahiro; Kumar, Sushil; Borkar, Rohan N et al. (2017) Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. Cell Rep 19:203-217
Kwon, Sunjong; Chin, Koei; Nederlof, Michel et al. (2017) Quantitative, in situ analysis of mRNAs and proteins with subcellular resolution. Sci Rep 7:16459
Midgett, Madeline; López, Claudia S; David, Larry et al. (2017) Increased Hemodynamic Load in Early Embryonic Stages Alters Endocardial to Mesenchymal Transition. Front Physiol 8:56
Krey, J F; Wilmarth, P A; David, L L et al. (2017) Analysis of the Proteome of Hair-Cell Stereocilia by Mass Spectrometry. Methods Enzymol 585:329-354
Xu, Xiaowei; De Angelis, Carmine; Burke, Kathleen A et al. (2017) HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer. Clin Cancer Res 23:5123-5134

Showing the most recent 10 out of 248 publications